Press Releases Evelo Biosciences, Inc.

Equities

EVLO

US2997342025

Market Closed - OTC Markets Other stock markets 09:47:15 09/05/2024 pm IST			5-day change	1st Jan Change
0.044 ^USD	0.00%		-11.11%	-28.46%

02/05	North American Morning Briefing : Stock Futures -2-	DJ
25/04	North American Morning Briefing : More Tech -2-	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis	17/23/17	AQ
Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights	14/23/14	AQ
Evelo Biosciences Closes $25.5 Million Private Placement	12/23/12	AQ
Evelo Biosciences Announces $25.5 Million Private Placement	10/23/10	AQ
Evelo Biosciences Announces Reverse Stock Split Effective	29/23/29	GL
Evelo Biosciences Announces Reverse Stock Split Effective	29/23/29	AQ
Evelo Biosciences : Other Information - Form 8-K	24/23/24	PU
Evelo Biosciences : Other Information - Form 8-K	17/23/17	PU
EVELO BIOSCIENCES, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	09/23/09	AQ
Evelo Biosciences : Other Information - Form 8-K	01/23/01	PU
Evelo Biosciences : Other Information - Form 8-K	23/23/23	PU
EVELO BIOSCIENCES, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	01/23/01	AQ
Evelo Biosciences Provides Clinical Updates	26/23/26	GL
EVELO BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)	19/23/19	AQ
Evelo Biosciences : Failure to Satisfy Listing Rule - Form 8-K	18/23/18	PU
EVELO BIOSCIENCES, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	18/23/18	AQ
EVELO BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	16/23/16	AQ
Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights	16/23/16	GL
Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights	16/23/16	AQ
Evelo Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023	09/23/09	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Evelo Biosciences, Inc.

Equities

EVLO

US2997342025

Press Releases

Filters